This was subsequently confirmed by the analysis of a gene expression microarray of 30 breast cancer cell lines, in which high mRNA expression of cPLA2α correlated with high EGFR expression and with the HER2-positive and basal-like subtypes of breast cancer in cell lines showing basal phenotype. This evidence concerns the gene EGFR and breast carcinoma.